Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Cancer research institute
Dec 30, 2023, 17:29 |
Blog
Paolo Tarantino: Ikigai
Paolo Tarantino, Medical Oncologist and Research Fellow at the Dana-Farber Cancer Institute, shared a post…
Dec 29, 2023, 15:35 |
Blog
Vivek Subbiah: Tumor-agnostic therapies advance possibilities for Precision Medicine
Vivek Subbiah shared on LinkedIn: ''Tumor-agnostic therapies advance possibilities for Precision Medicine. Genomics are driving…
Dec 29, 2023, 05:08 |
Blog
Vivek Subbiah: 1 in 3 academic physicians report they are considering leaving their institution within 2 years
Vivek Subbiah shared a post on X/Twitter: ''1 in 3 academic physicians report they are…
Dec 29, 2023, 04:56 |
Blog
Rosandra Kaplan: T cell and myeloid populations that contribute to GD2 CART expansion
Rosandra Kaplan, Senior Investigator Physician Scientist Pediatric Oncologist at National Cancer Institute (NCI), on LinkedIn:…
Dec 27, 2023, 17:02 |
Blog
Vivek Subbiah: Forward-thinking journal on AI in Oncology and precision medicine
Vivek Subbiah shared on X/Twitter: Just in time for the holidays. Nice to get the…
Dec 27, 2023, 14:02 |
Drugs
Vivek Subbiah: The FDA just finalized the draft guidance for 'RARE DISEASE DRUG DEVELOPMENT'
Vivek Subbiah recently shared on LinkedIn: "Wow! The FDA just finalized the draft guidance for…
Dec 27, 2023, 08:59 |
Insight
Jonas Nilsson: Interesting and balanced discussion on a recent safety signal of CAR-T cells in plasma cell disorders
Jonas Nilsson Chair of Melanoma Discovery at The University of Western Australia and Harry Perkins…
Dec 26, 2023, 04:08 |
Dialogues
OncoDaily Dialogues #4 - Therese Mulvey / Hosted by Roupen Odabashian
In our series "OncoDaily Dialogues," we continue to spotlight eminent figures in oncology, sharing their…
Dec 25, 2023, 16:45 |
Insight
Vivek Subbiah: Pleased to share the work of our amazing RET precision medicine team as we review
Vivek Subbiah shared on LinkedIn: "Hot off the press! Pleased to share the work of…
Dec 24, 2023, 18:54 |
Drugs
Laurie Glimcher: Belzutifan is approved by the FDA
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X/Twitter: "Exciting news that…
258
259
260
261
262
All:
2805
Posts:
2591 - 2600
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube